GO:0071816 tail-anchored membrane protein insertion into ER membrane: Protein Targeting Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0071816 describes the post-translational insertion of tail-anchored (TA) proteins into the endoplasmic reticulum (ER) membrane, a process independent of the Sec61 translocon [1, 5].
• TA proteins are defined by a single C-terminal transmembrane domain and include essential regulators of membrane trafficking, apoptosis, and calcium homeostasis [1, 4].
• The central cytosolic targeting factor is the Get3/TRC40 ATPase, which delivers TA proteins to the ER membrane receptors Get1/Get2 (yeast) or WRB/CAML (metazoans) [2, 3, 4].
• Insertion is regulated by nucleotide binding and hydrolysis, and can be modulated by calcium-calmodulin signaling in mammalian cells [3, 6].
• Defects in TA protein insertion are linked to cancer, neurodegeneration, and developmental disorders, making this pathway a therapeutic target [4, 7].
• Research methods include in vitro insertion assays, cryo-EM, and CRISPR-based screens to dissect the molecular machinery [2, 8].
Description
Tail-anchored (TA) membrane proteins are a class of integral membrane proteins that possess a single transmembrane domain at their extreme C-terminus, with the bulk of the protein facing the cytosol. These proteins are involved in a wide range of cellular processes, including vesicle trafficking, apoptosis, and protein quality control [1, 4]. Unlike most membrane proteins, TA proteins are inserted into the endoplasmic reticulum (ER) membrane post-translationally, after their synthesis is completed on cytosolic ribosomes [1, 5]. This distinct targeting route ensures that the hydrophobic transmembrane domain is shielded from the cytosol and correctly integrated into the ER lipid bilayer. The Gene Ontology term GO:0071816, tail-anchored membrane protein insertion into ER membrane, captures this essential biological process. Understanding this pathway is crucial because its dysfunction has been implicated in human diseases such as cancer and neurodegeneration [4, 7]. Moreover, the machinery involved represents a potential target for therapeutic intervention.
tail-anchored membrane protein insertion into ER membrane At A Glance
| GO ID | GO:0071816 |
|---|---|
| GO term | tail-anchored membrane protein insertion into ER membrane |
| Ontology | biological_process |
| Synonym | protein insertion of tail-anchored membrane proteins into ER membrane; tail-anchored membrane protein insertion into endoplasmic reticulum membrane; type II transmembrane protein insertion into ER membrane |
| Major function | Post-translational insertion of TA proteins into the ER membrane |
| Key machinery | Get3/TRC40 ATPase, Get1/Get2 (yeast), WRB/CAML (metazoans) |
| Cellular location | Endoplasmic reticulum membrane |
| Pathway type | Post-translational translocation |
What Is GO:0071816?
GO:0071816 is defined as the process of protein insertion into the endoplasmic reticulum (ER) membrane in which a tail-anchored (TA) transmembrane protein is incorporated into an ER membrane. TA transmembrane proteins, also known as type II transmembrane proteins, contain a single C-terminal transmembrane region.
Why Is tail-anchored membrane protein insertion into ER membrane Important in Cell Biology?
The insertion of tail-anchored proteins into the ER membrane is essential for numerous cellular functions, including membrane trafficking, apoptosis, and calcium signaling [1, 4]. Defects in this pathway can lead to mislocalization of TA proteins, which is associated with cancer progression, neurodegeneration, and developmental disorders [4, 7]. Therefore, understanding the molecular mechanisms of TA protein insertion is critical for identifying therapeutic targets and developing treatments for related diseases.
• TA proteins include SNAREs, Bcl-2 family members, and cytochrome b5, which are vital for vesicle fusion, apoptosis, and lipid metabolism.
• The GET pathway (guided entry of TA proteins) is conserved from yeast to humans, highlighting its fundamental importance.
• Mutations in GET pathway components are linked to diseases such as intellectual disability and cancer [4, 7].
• TA protein mislocalization can contribute to neurodegeneration by disrupting ER-mitochondria communication.
• The pathway is a potential target for antiviral and anticancer therapies.
• Studying TA protein insertion provides insights into general principles of membrane protein biogenesis.
• Defects in TA protein insertion can trigger ER stress and unfolded protein response.
• The pathway is regulated by calcium-calmodulin, linking it to cellular signaling.
• TA proteins are involved in immune response and inflammation.
• Understanding TA protein insertion can aid in the design of biologics targeting membrane proteins.
What Happens During tail-anchored membrane protein insertion into ER membrane?
Recognition and Targeting of TA Proteins
In simple terms: The cell identifies TA proteins and prepares them for delivery to the ER.
After synthesis on cytosolic ribosomes, TA proteins are recognized by the cytosolic ATPase Get3 (yeast) or TRC40 (metazoans) [1, 3]. This targeting factor binds the hydrophobic transmembrane domain, preventing aggregation and facilitating delivery to the ER membrane. The interaction is ATP-dependent and involves a conformational change in Get3.
Docking at the ER Membrane
In simple terms: The targeting factor brings the TA protein to the ER membrane and docks onto receptor proteins.
The Get3-TA protein complex docks at the ER membrane via the receptors Get1 and Get2 (yeast) or WRB and CAML (metazoans) [2, 4]. These receptors form a heteromeric complex that coordinates the transfer of the TA protein into the lipid bilayer. Cryo-EM studies have revealed the architecture of the Get3-Get1/Get2 complex, providing mechanistic insights.
Insertion into the ER Membrane
In simple terms: The TA protein is inserted into the ER membrane, and the targeting factor is released.
Following docking, the TA protein is inserted into the ER membrane in a process that requires ATP hydrolysis by Get3. The transmembrane domain partitions into the lipid bilayer, while the Get3 ATPase is released for another cycle. This insertion step is independent of the Sec61 translocon and other Sec machinery.
Regulation by Calcium-Calmodulin
In simple terms: Calcium signals can inhibit the insertion process by interacting with calmodulin.
In mammalian cells, calcium-calmodulin has been shown to inhibit TA protein insertion into the ER membrane. This regulation may provide a means to modulate TA protein biogenesis in response to cellular calcium levels.
Key Genes Involved in GO:0071816 tail-anchored membrane protein insertion into ER membrane
The following genes and proteins are key components of the tail-anchored membrane protein insertion pathway.
| Gene | Major Role | Research Relevance |
|---|---|---|
| GET3 | ATPase that binds TA proteins and delivers them to the ER | Central targeting factor; mutations affect TA protein insertion |
| GET1 | ER membrane receptor for Get3 | Forms complex with Get2; essential for TA protein release |
| GET2 | ER membrane receptor for Get3 | Works with Get1 to facilitate insertion |
| TRC40 | Metazoan homolog of Get3 | Functions in TA protein targeting in mammals |
| WRB | Metazoan receptor for TRC40 | Mutations linked to developmental disorders |
| CAML | Metazoan receptor for TRC40 | Partners with WRB in TA protein insertion |
| SEC61 | ER translocon for co-translational translocation | Not required for TA protein insertion |
| BAG6 | Chaperone involved in TA protein quality control | Assists in TA protein targeting |
| SGTA | Co-chaperone that binds TA proteins | Facilitates TA protein delivery to TRC40 |
| UBL4A | Component of BAG6 complex | Involved in TA protein biogenesis |
| GET4 | Component of Get3 targeting complex | Regulates Get3 function |
| GET5 | Component of Get3 targeting complex | Regulates Get3 function |
| SNARE proteins | TA proteins involved in vesicle fusion | Require GET pathway for insertion |
| BCL-2 family | TA proteins regulating apoptosis | Insertion defects affect cell death |
| Cytochrome b5 | TA protein in lipid metabolism | Model TA protein for insertion studies |
| VAMP | TA protein in synaptic vesicle fusion | Requires TA insertion for function |
| Syntaxin | TA protein in membrane fusion | TA insertion essential for activity |
How Is tail-anchored membrane protein insertion into ER membrane Regulated?
The tail-anchored membrane protein insertion pathway is regulated at multiple levels. The ATPase activity of Get3/TRC40 is critical for its function, with nucleotide binding and hydrolysis driving conformational changes necessary for TA protein transfer. In mammalian cells, calcium-calmodulin signaling inhibits TA protein insertion, suggesting a regulatory role for calcium. Additionally, the expression levels of GET pathway components can be modulated under stress conditions, although specific transcriptional regulators remain to be fully elucidated.
tail-anchored membrane protein insertion into ER membrane and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| WRB | Developmental disorder with intellectual disability | Knockout mice or patient-derived iPSCs |
| GET3 | Cancer (e.g., altered apoptosis) | Cancer cell lines with GET3 knockout |
| BCL-2 | Cancer (apoptosis evasion) | Overexpression or point mutants in cancer models |
| VAMP | Neurodegeneration (synaptic dysfunction) | Neuronal cultures with VAMP mutations |
| TRC40 | Neurodegeneration | Knockdown in neuronal cell lines |
Cancer
Dysregulation of TA protein insertion can contribute to cancer by affecting the localization of oncogenes or tumor suppressors. For example, mislocalization of Bcl-2 family proteins, which are TA proteins, can alter apoptotic signaling and promote tumor survival. Targeting the GET pathway may offer therapeutic opportunities in cancers dependent on TA protein function.
Neurodegeneration
Neurons are particularly sensitive to defects in membrane protein trafficking. Mutations in WRB, a receptor for TRC40, have been linked to developmental disorders with neurological features. Impaired TA protein insertion may disrupt ER-mitochondria communication and contribute to neurodegeneration.
Developmental Disorders
Mutations in components of the TA protein insertion machinery, such as WRB, are associated with intellectual disability and developmental delay. These disorders highlight the importance of proper TA protein biogenesis for human development.
From tail-anchored membrane protein insertion into ER membrane-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the effect of GET3 knockout on TA protein insertion? | CRISPR knockout in HEK293 cells |
| How do point mutations in WRB affect TA protein targeting? | Knock-in of patient mutations in iPSCs |
| Can overexpression of TRC40 rescue insertion defects? | Overexpression in Get3-deficient yeast |
| Where does Get3 localize during insertion? | Tagged knock-in of GFP-Get3 in yeast |
| What is the role of calcium-calmodulin in TA insertion? | Point mutation of calmodulin binding sites |
| How does loss of Get1 affect ER morphology? | Knockout in mammalian cells followed by imaging |
How to Study the tail-anchored membrane protein insertion into ER membrane Process
| Method | What It Measures | Typical Application |
|---|---|---|
| In vitro insertion assay | Efficiency of TA protein insertion into ER membranes | Mechanistic studies of GET pathway components |
| Cryo-EM | High-resolution structure of insertion complexes | Understanding molecular architecture |
| CRISPR knockout screen | Genes required for TA protein insertion | Identifying novel pathway components |
| Fluorescence microscopy | Localization of TA proteins and machinery | Live-cell imaging of insertion |
| Co-immunoprecipitation | Protein-protein interactions | Mapping the GET pathway interactome |
| ATPase assay | Get3/TRC40 ATP hydrolysis activity | Functional characterization of mutants |
| Protease protection assay | Membrane integration of TA proteins | Confirming successful insertion |
| Ribo-seq | Translation of TA proteins | Global analysis of TA protein synthesis |
In Vitro Insertion Assays
In vitro assays using isolated ER membranes and radiolabeled TA proteins are classic methods to study insertion. These assays can be coupled with proteolysis to assess membrane integration. They allow precise control of components and are useful for mechanistic studies.
Cryo-Electron Microscopy
Cryo-EM has provided high-resolution structures of the Get3-Get1/Get2 complex and TRC40-WRB-CAML, revealing how TA proteins are transferred into the membrane. This method is essential for understanding conformational changes during insertion.
CRISPR Screens
Genome-wide CRISPR knockout screens can identify genes required for TA protein insertion. For example, a reporter TA protein fused to a fluorescent tag can be used to monitor insertion efficiency, and loss of insertion can be selected for.
Proteomics and Interaction Studies
Affinity purification coupled with mass spectrometry can identify novel interactors of GET pathway components. Crosslinking mass spectrometry can map contact sites between Get3 and TA proteins.
How CRISPR Can Be Used to Study GO:0071816 tail-anchored membrane protein insertion into ER membrane
Knockout
CRISPR knockout of GET3, GET1, GET2, or their mammalian homologs can abolish TA protein insertion, leading to mislocalization and degradation of TA proteins. Such knockouts are valuable for studying the consequences of pathway loss and for identifying compensatory mechanisms.
Point Mutation
Introducing point mutations in GET3 that impair ATP binding or hydrolysis can dissect the role of nucleotide cycling in TA protein insertion. Similarly, mutations in WRB found in patients can be modeled to understand disease mechanisms.
Knock-in
Knock-in of tagged versions of GET3 or TRC40 (e.g., GFP or HA) allows visualization and purification of the targeting complex in native cells. This approach is useful for studying dynamic localization and interactions.
Overexpression
Overexpression of GET pathway components can rescue insertion defects or amplify the pathway for biochemical studies. It can also be used to test dominant-negative effects of mutant proteins.
How EDITGENE Supports tail-anchored membrane protein insertion into ER membrane Research
Researchers studying tail-anchored membrane protein insertion into ER membrane-related genes often need to determine whether a candidate gene is causally involved in the pathway or in disease. EDITGENE provides a comprehensive suite of CRISPR services to enable such investigations.
Contact EDITGENE today to design your custom CRISPR model for tail-anchored membrane protein insertion into ER membrane research.
Frequently Asked Questions About tail-anchored membrane protein insertion into ER membrane
What is GO:0071816?
GO:0071816 is the Gene Ontology term for the biological process of tail-anchored membrane protein insertion into the ER membrane, where TA proteins are post-translationally inserted into the ER.
What genes are involved in tail-anchored membrane protein insertion into ER membrane?
Key genes include GET3, GET1, GET2 in yeast, and TRC40, WRB, CAML in mammals, as well as BAG6 and SGTA [1, 4].
How are tail-anchored proteins inserted into the ER?
TA proteins are recognized by Get3/TRC40, delivered to ER receptors Get1/Get2 or WRB/CAML, and inserted into the membrane in an ATP-dependent manner [3, 4].
What is the role of Get3 in TA protein insertion?
Get3 is an ATPase that binds TA proteins and targets them to the ER membrane for insertion.
Is the Sec61 translocon required for TA protein insertion?
No, TA protein insertion is independent of the Sec61 translocon and other Sec machinery.
What diseases are associated with defects in TA protein insertion?
Defects have been linked to cancer, neurodegeneration, and developmental disorders such as those caused by WRB mutations.
How can I study TA protein insertion in the lab?
Common methods include in vitro insertion assays, cryo-EM, CRISPR screens, and fluorescence microscopy [2, 8].
What is the GET pathway?
The GET (guided entry of TA proteins) pathway is the machinery that mediates TA protein insertion into the ER, conserved from yeast to humans.
Can calcium regulate TA protein insertion?
Yes, calcium-calmodulin has been shown to inhibit TA protein insertion into the mammalian ER membrane.
What model systems are used to study TA protein insertion?
Yeast, mammalian cell lines, and in vitro systems with isolated ER membranes are commonly used [5, 8].
Conclusion
GO:0071816 represents a vital cellular process for the correct localization of tail-anchored proteins, which are involved in diverse functions from apoptosis to vesicle trafficking. The GET pathway and its mammalian counterparts have been elucidated through decades of research, revealing a post-translational mechanism independent of the Sec machinery. Dysregulation of this pathway is implicated in human diseases, making it a target for therapeutic intervention. Continued research using advanced CRISPR models and structural biology will further illuminate the molecular details and disease relevance of TA protein insertion.
References
- 1. Hegde RS et al.. 2011. Tail-anchored membrane protein insertion into the endoplasmic reticulum.. Nat Rev Mol Cell Biol 12(12):787-98 PMID: 22086371
- 2. Sinning I et al.. 2022. Cryo-EM insights into tail-anchored membrane protein biogenesis in eukaryotes.. Curr Opin Struct Biol 75:102428 PMID: 35850079
- 3. Wang F et al.. 2011. The mechanism of tail-anchored protein insertion into the ER membrane.. Mol Cell 43(5):738-50 PMID: 21835666
- 4. Guna A et al.. 2023. A TAle of Two Pathways: Tail-Anchored Protein Insertion at the Endoplasmic Reticulum.. Cold Spring Harb Perspect Biol 15(3) PMID: 36041783
- 5. Steel GJ et al.. 2002. Tail-anchored protein insertion into yeast ER requires a novel posttranslational mechanism which is independent of the SEC machinery.. Biochemistry 41(39):11914-20 PMID: 12269836
- 6. Hassdenteufel S et al.. 2011. Ca2+-calmodulin inhibits tail-anchored protein insertion into the mammalian endoplasmic reticulum membrane.. FEBS Lett 585(21):3485-90 PMID: 22001204
- 7. Mehlhorn DG et al.. 2021. Looking for a safe haven: tail-anchored proteins and their membrane insertion pathways.. Plant Physiol 187(4):1916-1928 PMID: 35235667
- 8. Cho H et al.. 2018. In vitro Assays for Targeting and Insertion of Tail-Anchored Proteins Into the ER Membrane.. Curr Protoc Cell Biol 81(1):e63 PMID: 30253068
